Cirrhosis News and Research

Latest Cirrhosis News and Research

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Researchers investigated the link between non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2DM) and all-cause death and cardiovascular disease.

16 Feb 2024

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that's fast and complete in one step. Industrial production is targeted for use throughout the country.

15 Feb 2024

Blood biomarkers in TGF-β pathway identify hidden liver cancer risk

A new research paper was published in Genes & Cancer on February 5, 2023, entitled, "Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis."

9 Feb 2024

Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts

The COVID-19 pandemic's influence on healthcare systems led to mixed outcomes for patients with cirrhosis, showing stable infection rates but a rise in multi-drug resistant organism (MDRO) infections.

7 Feb 2024

Viscoelasticity emerges as key marker for liver cancer in diabetes

For centuries, doctors have used their hands as essential diagnostic tools -; exploring joints and palpating abdomens to assess a patient's health.

2 Feb 2024

Study: Up to 10% of dementia cases in veterans may be caused by liver disease

As many as 10% of older U.S. veterans diagnosed with dementia may suffer instead from reversible cognitive decline caused by advanced liver disease, according to an analysis from the Virginia Commonwealth University's School of Medicine and the Richmond VA Medical Center.

31 Jan 2024

NHS health checks linked to reduced risk of heart, brain, kidney, and liver diseases

A study analyzing UK Biobank data found that individuals who underwent the NHS health evaluation had a lower long-term risk of various diseases and mortality compared to those who did not participate in the assessment.

24 Jan 2024

Dietary carotenoids may reduce risk of non-alcoholic fatty liver disease, study suggests

Study found no direct link between total dietary vitamin A intake and non-alcoholic fatty liver disease (NAFLD) risk, but observed an inverse correlation between provitamin A carotenoid consumption and NAFLD risk.

23 Jan 2024

3D-printed liver model paves way for new MASH treatments

Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD).

23 Jan 2024

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet in Sweden published in the journal Gut.

23 Jan 2024

NHS Health Check linked to lower disease rates and mortality, study shows

Attending an NHS Health Check appointment -; a preventative screening programme offered for free in the UK -; is associated with both a decreased risk of dying and a decreased risk of several diseases, including dementia and liver cirrhosis.

22 Jan 2024

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers investigate the need for prioritizing COVID-19 booster vaccination.

19 Jan 2024

TRPC3 emerges as key player in preventing damage from alcohol-associated liver disease

Excessive alcohol intake is strongly associated with alcohol-associated liver disease (ALD) which accounts for 25% and 30% of deaths from cirrhosis and hepatocellular carcinoma. Impairment of Ca2+ influx and Ca2+-mediated signaling in ALD suggests that Ca2+ channels are important in ALD pathological progression.

16 Jan 2024

New imaging technique could transform diagnosis and treatment of steatotic liver disease

Steatotic liver disease (SLD), previously known as non-alcoholic fatty liver disease, which includes a range of conditions caused by fat build-up in the liver due to abnormal lipid metabolism, affects about 25% of the population worldwide, making it the most common liver disorder.

9 Jan 2024

£30M clinical study will enhance the understanding of NASH cirrhosis

The most extensive clinical study into liver cirrhosis ever conducted worldwide has been announced by Newcastle University, University of Edinburgh and leading research-driven global biopharmaceutical company, Boehringer Ingelheim.

8 Jan 2024

Gut microbes revealed as key players in liver disease solutions

In the editorial published on 4 September 2023, in the "gut-liver axis" special issue of the journal Hepatobiliary & Pancreatic Diseases International, Dr. Jian-Gao Fan and Dr. Lu Jiang from Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine provided a comprehensive elucidation of the pivotal role of gut microbiota in various liver diseases.

4 Jan 2024

Cirrhosis News and Research

Latest Cirrhosis News and Research

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Blood biomarkers in TGF-β pathway identify hidden liver cancer risk

Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts

Viscoelasticity emerges as key marker for liver cancer in diabetes

Study: Up to 10% of dementia cases in veterans may be caused by liver disease

NHS health checks linked to reduced risk of heart, brain, kidney, and liver diseases

Dietary carotenoids may reduce risk of non-alcoholic fatty liver disease, study suggests

3D-printed liver model paves way for new MASH treatments

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

NHS Health Check linked to lower disease rates and mortality, study shows

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

TRPC3 emerges as key player in preventing damage from alcohol-associated liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

£30M clinical study will enhance the understanding of NASH cirrhosis

Gut microbes revealed as key players in liver disease solutions

Exploring the global health challenge of hepatitis D

Simple mail trick doubles liver cancer screening rates for high-risk patients

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Study points to binge drinking and genetics as key factors in liver disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cirrhosis News and Research

Latest Cirrhosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in